All updates
All updates
today 37中文产业新闻Chinese source评分4040 中文产业新闻Chinese source评分6262 恒瑞医药与诺和诺德就口服GLP-1/GIP双受体激动剂HRS-1596达成最高26亿美元授权合作
中文产业新闻Chinese source评分4949 默沙东与阿斯利康在两天内达成两笔20亿美元级BD交易，涉及KRAS G12D抑制剂和PD-1/VEGF双抗
中文产业新闻Chinese source评分5353 阿斯利康以20亿美元入股Summit Therapeutics获12%股权，押注双抗药物依沃西
中文产业新闻Chinese source评分5656 恒瑞医药将 GLP-1/GIP 双受体激动剂 HRS-1596 授权诺和诺德，交易总额最高 26 亿美元
STAT News评分1111 STAT+: UnitedHealth investor lawsuit moves forward on allegations it ‘manufactured earnings’ to hide declining profits
监管与产业动态评分88 Organon beams up 'Skin Science' in sci-fi themed Vtama campaign - Fierce Pharma
监管与产业动态评分1212 BioMarin lays off 117 California workers to consolidate footprint - Fierce Pharma
监管与产业动态评分1717 Novo trims 108 jobs at US headquarters in New Jersey - Fierce Pharma
Endpoints News评分2727 Varda gets $251M to make medicines in space, a long-sought area for drugs
监管与产业动态评分2626 Varda brings home $251M series D to fuel space-based drug manufacturing - Fierce Pharma
BioSpace评分1919 $40M in tax incentives expected to generate 1,600+ life sciences jobs in Massachusetts
BioPharma Dive评分2828 PhRMA names next CEO; Pierre Fabre takes third swing at Ebvallo approval
监管与产业动态评分1818 Beam Therapeutics sues base editing rival, claims former scientist stole secrets - Fierce Biotech
Endpoints News评分2020 Ned Sharpless joins Hatteras, as Andrew Witty returns to the VC firm as chairman
BioSpace评分88 2026 IPO stock tracker: How newly public biotechs are performing
BioSpace评分3333 BioNTech to close German manufacturing plants after failing to find buyers
STAT News评分1616 STAT+: Pharmalittle: We’re reading about Beam suing over IP theft, a Trump rule on importing meds, and more
STAT News评分2020 STAT+: Three biotech updates, including accusations of theft and and a new lobbying leader
监管与产业动态评分88 CSL’s Seqirus unit boasts bigger batch of flu vaccines ahead of U.S. flu season - Fierce Pharma
监管与产业动态评分2222 GSK continues to stock up on Wave's RNA drugs with liver-focused program - Fierce Biotech
监管与产业动态评分3232 NorthStar locks down $185M as radiopharmaceutical isotope, CDMO expansion plans advance - Fierce Pharma
BioSpace评分2929 AstraZeneca buys into Summit, UniQure drops on 4-year data, FDA on a roll
监管与产业动态评分66 Alnylam drafts football veteran Pete Shaw for heart disease education push - Fierce Pharma
BioSpace评分2222 No ‘Sunday scaries’: Claire Mazumdar on building Bicara—and knowing when to hand over the reins
Endpoints News评分2626 Beam sues YolTech and Serapha Bio for allegedly stealing its gene editing tech
BioPharma Dive评分3232 Beam sues 2 biotechs, alleging theft of base editing trade secrets
监管与产业动态评分1515 Signal or noise? > Enanta sheds staffers as key antiviral, immunology readouts loom >> Comment below! #strategy #competitiveintelligence #marketing #pharmaceutical #pharma #healthcare #competitivemarketing #biotech
Endpoints News评分1515 PhRMA picks Eric Cantor as next chief
STAT News精选评分3535 STAT+: Beam Therapeutics sues Chinese biotech, VC-backed startup, alleging theft of intellectual property
STAT News评分1313 STAT+: PhRMA taps Eric Cantor as new CEO
监管与产业动态评分1111 PhRMA locks in former House Majority Leader Cantor as next CEO - Fierce Pharma
监管与产业动态评分1616 Enanta sheds staffers as key antiviral, immunology readouts loom - Fierce Biotech
Endpoints News精选评分4141 Merck licenses a KRAS G12D inhibitor for $400M upfront
Endpoints News评分1111 Scynexis' BARDA alliance; Bristol Myers' early data for dual-targeting CAR-T
Endpoints News评分4040 AstraZeneca buys a $2B stake in Summit, taking equity in bet on cancer drug
Endpoints News精选评分3030 BioNTech to close three sites in Germany after failing to secure a sale
Endpoints News评分3030 Swedish biotech AnaCardio raises $70.9M to advance 'safer' heart failure drug
Endpoints News评分4141 Novo to spend $300M upfront to license Hengrui's weekly oral weight loss drug
STAT News评分2424 STAT+: Pharmalittle: We’re reading about GLP-1s becoming lifestyle drugs, a setback for Merck and Daiichi, and more